Global Infant Clinical Nutrition Market estimated to surpass US$ 31,000 Mn in revenues by 2026-end

Malnutrition in children prevails as a grave concern worldwide. Increasing birth rate coupled with mounting number of premature births has led toward demand for nutrition-rich supplements for young infants. Extremely preterm infants require high nutrition supply that is challenging to meet as growth faltering is common. In adequate growth has further been linked with poor neurodevelopmental outcomes. Although improved early growth in children is associated with good cognitive outcomes, possibility of a trade-off based on worse metabolic outcomes exists.

Request Free Sample Report @ https://www.mrrse.com/sample/4709

Several new developments have been witnessed in infant clinical nutrition that include recommendations on increasing protein supply, improving lipid formulations, and providing mineral supplements while promoting human milk feeding. Focus of researches carried out on infant clinical nutrition is being directed toward new formula products with potential of improving metabolic and cognitive outcomes. Provision of effective nutrition to infants is being prioritized as an imperative focus of researches associated with neonatal care, with an aim of improving long-term developmental and metabolic outcomes.

The National Health Service has recently published standards that mandate screening of all infants for undernutrition post-birth along with periodic examinations. Researchers across the globe are focusing on the development of appropriate nutritional screening tools for children on admission. These tools are likely to facilitate identification of infants who are at high risk of undernutrition as well as those who are undernourished, further benefitting from referral for complete nutritional assessment with the help of a dietician.

A recently published Market Research Reports Search Engine report has projected the global infant clinical nutrition market to exhibit a splendid growth between the period 2017 and 2026. Worldwide sales of infant clinical nutrition products are estimated to surpass US$ 31,000 Mn in revenues by 2026-end.

Revenues from sales of infant clinical nutrition products in Asia-Pacific excluding Japan (APEJ) is set to record an impressive expansion, to account for the largest market revenue share during the forecast period. Robust birth rates coupled with surging prevalence of undernutrition and malnutrition in the region’s child population are major factors contributing to demand for infant clinical nutrition in APEJ. Europe will also remain a remunerative region for growth of the infant clinical nutrition market, with ample availability of various clinical nutrition products, and provision of favorable reimbursements by the healthcare system in the region.

Milk-based infant clinical nutrition are likely to remain sought-after among products in the market, with a revenue share significantly larger than that of all the other products combined. This is mainly because of the fact that children consuming various alternatives of nutrition such as soy-based are likely to have relatively lower developmental outcomes as compared to those consuming milk-based products.

Although revenue from enteral route of administration for infant clinical nutrition products will increase at a relatively higher CAGR through 2026, revenues from oral administration of infant clinical nutrition will remain the largest in the market.

To know the latest trends and insights prevalent in this market, click the link below: https://www.mrrse.com/infant-clinical-nutrition-market

Leading players in the global infant clinical nutrition market are continuously focusing on innovation, with growing consumer requirement for premium quality products that comprise novel ingredients. Regulatory norms mandate sound scientific intelligence for companies launching new product in the market. In addition, the market players are continuously investing in the development of effective and efficient processing methods in their factories for coping with the global rise in demand, meanwhile concentrating on minimizing their environmental footprint. Key participants guiding expansion of the global infant clinical nutrition market include Abbott, Baxter International, Inc., Fresenius Kabi AG, Groupe Danone, Nutricia North America, Mead Johnson Nutrition Company, Meiji Co., Ltd., Nestlé Health Science S.A., B. Braun Melsungen.

About Market Research Reports Search Engine

Market Research Reports Search Engine (MRRSE) is an industry-leading database of Market Research Reports. MRRSE is driven by a stellar team of research experts and advisors trained to offer objective advice. Our sophisticated search algorithm returns results based on the report title, geographical region, publisher, or other keywords.

MRRSE partners exclusively with leading global publishers to provide clients single-point access to top-of-the-line market research. MRRSE’s repository is updated every day to keep its clients ahead of the next new trend in market research, be it competitive intelligence, product or service trends or strategic consulting.

Contact Us

State Tower
90, State Street
Suite 700
Albany, NY – 12207(United State)
United States Telephone: +1-518-730-0559(Canada)
Email: sales@mrrse.com
Website: https://www.mrrse.com/

This release was published on openPR.